1. Home/
  2. Compounds/
  3. selumetinib:piperlongumine (8:1 mol/mol)

selumetinib:piperlongumine (8:1 mol/mol)

Synonyms

SourcesNames Used
CTRPv2selumetinib:piperlongumine (8:1 mol/mol)
PharmacoGx selumetinib:piperlongumine (8:1 mol/mol)

FDA Approval Status

Not Approved
Dataset Select
Download Data as CSV

Top molecular features associated with response to selumetinib:piperlongumine (8:1 mol/mol)


Feature TypeStandardized
Nominal ANOVA
mRNA ATG9B CTRPv2 pan-cancer AAC 0.13 0.0003
mRNA ARHGEF11 CTRPv2 pan-cancer AAC 0.15 0.0003
mRNA ITGA9 CTRPv2 pan-cancer AAC 0.14 0.0003
mRNA MASTL CTRPv2 pan-cancer AAC -0.13 0.0003
mRNA IL1RAP CTRPv2 pan-cancer AAC 0.14 0.0003
mRNA RFTN1 CTRPv2 pan-cancer AAC -0.13 0.0003
mRNA MIPEP CTRPv2 pan-cancer AAC 0.14 0.0003
mRNA CNPY1 CTRPv2 pan-cancer AAC 0.12 0.0003
mRNA PEAK1 CTRPv2 pan-cancer AAC -0.14 0.0004
mRNA CFP CTRPv2 pan-cancer AAC 0.13 0.0004
Download CSV